Following the exercise of share options by option holders under Elliptic Laboratories ASA's ("Elliptic Labs" or the "Company") share option program, the Company's board of directors has, based on the authorization granted by the general meeting on 23 May 2022, resolved to increase the Company's share capital by NOK 233.40, by the issuance of 23 340 new shares, at a subscription price of NOK 15.00 per share.
After the issuance of the new shares, the share capital will be NOK 1 040 742.10 divided into 104 074 210 shares, each with a par value of NOK 0.01.
All the exercised options have been granted in accordance with the Company's share option program described in the Company's latest annual financial statement.
Recent Comments